BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29333942)

  • 1. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
    Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
    Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation.
    Chu Y; Jiang M; Wu N; Xu B; Li W; Liu H; Su S; Shi Y; Liu H; Gao X; Fu X; Chen D; Li X; Wang W; Liang J; Nie Y; Fan D
    Theranostics; 2020; 10(21):9830-9842. PubMed ID: 32863962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.
    Liu L; Chen X; Xie S; Zhang C; Qiu Z; Zhu F
    Hepatology; 2012 Nov; 56(5):1760-9. PubMed ID: 22576474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factorIRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway.
    Zhu L; Dai L; Yang N; Liu M; Ma S; Li C; Shen J; Lin T; Wang D; Pan W; Li X
    Cell Biochem Funct; 2020 Jul; 38(5):621-629. PubMed ID: 32153043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
    Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
    J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25(OH)
    Huang J; Yang G; Huang Y; Zhang S
    Biochimie; 2018 Mar; 146():28-34. PubMed ID: 29158005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
    Chang TM; Hung WC
    Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sineoculis Homeobox Homolog 1 (SIX1) Gene Regulates Paclitaxel Resistance by Affecting Reactive Oxygen Species and Autophagy in Human Hepatocellular Carcinoma Cell Line HepG2.
    Li B; Zhao S; Geng R; Huo Z; Zhang H
    Med Sci Monit; 2018 Apr; 24():2271-2279. PubMed ID: 29656300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
    Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RITA inhibits growth of human hepatocellular carcinoma through induction of apoptosis.
    Wang H; Chen G; Wang H; Liu C
    Oncol Res; 2013; 20(10):437-45. PubMed ID: 24308154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
    Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
    J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
    Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
    Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The let-7c/HoxB7 axis regulates the cell proliferation, migration and apoptosis in hepatocellular carcinoma.
    Cai L; Wang Z; Zheng H; Xu L
    Anticancer Drugs; 2020 Jan; 31(1):6-18. PubMed ID: 31609764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dachshund binds p53 to block the growth of lung adenocarcinoma cells.
    Chen K; Wu K; Cai S; Zhang W; Zhou J; Wang J; Ertel A; Li Z; Rui H; Quong A; Lisanti MP; Tozeren A; Tanes C; Addya S; Gormley M; Wang C; McMahon SB; Pestell RG
    Cancer Res; 2013 Jun; 73(11):3262-74. PubMed ID: 23492369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression.
    Rong Z; Wang Z; Wang X; Qin C; Geng W
    J Exp Clin Cancer Res; 2020 Apr; 39(1):61. PubMed ID: 32272940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
    Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
    Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.